Methicillin-resistant Staphylococcus aureus infections in children

Douglas S Swanson1

  • 1Department of Pediatrics, University of Missouri-Kansas City School of Medicine, USA.

Missouri Medicine
|April 4, 2006
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) is a growing concern, causing skin infections and serious invasive diseases in the US. Treatment depends on local resistance patterns and infection severity, especially in pediatric cases.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Resistance
  • Bacterial Pathogenesis

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) presents a significant and increasing public health challenge in the United States.
  • MRSA infections manifest commonly as skin and soft tissue infections but can progress to severe invasive disease affecting any organ system.

Purpose of the Study:

  • To review the epidemiology of MRSA infections in children.
  • To describe the clinical features associated with pediatric MRSA infections.
  • To outline current treatment considerations for MRSA in pediatric populations.

Main Methods:

  • Literature review of epidemiological data on MRSA.
  • Analysis of clinical case studies and reports on MRSA infections in children.
  • Synthesis of current treatment guidelines and antimicrobial susceptibility data.

Main Results:

  • MRSA is an emerging pathogen in both pediatric and adult populations across the US.
  • Skin and soft tissue infections are the most frequent presentation, but invasive MRSA disease can occur.
  • Empirical treatment strategies must account for regional antimicrobial susceptibility patterns and disease severity.

Conclusions:

  • Understanding MRSA epidemiology and clinical presentations is crucial for effective management in children.
  • Treatment decisions for pediatric MRSA require careful consideration of local resistance data and infection severity.
  • This review provides essential information for clinicians managing MRSA infections in pediatric patients.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...